Search research articles
Contact Us
Filters
Showing results (181-190 of 194) with videos related to
Page
of 20
Sort By:
Nature Communications
|
April 5, 2019
NKG2A is a NK cell exhaustion checkpoint for HCV persistence
Chao Zhang, Xiao-Mei Wang, Shu-Ran Li, et al.
NAR Genomics and Bioinformatics
|
August 8, 2022
Mining bacterial NGS data vastly expands the complete genomes of temperate phages
Xianglilan Zhang, Ruohan Wang, Xiangcheng Xie, et al.
JAMA Network Open
|
February 24, 2025
Tetramethylpyrazine Nitrone in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial
Xiaolu Liu, Huifang Shang, Qianqian Wei, et al.
Journal of Digestive Diseases
|
February 2, 2018
Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo-controlled phase 2 trial
Yong Feng Wang, Jie Ting Tang, Tao Han, et al.
Hepatology International
|
July 24, 2015
Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients
Ji-Dong Jia, Jin-Lin Hou, You-Kuan Yin, et al.
Plos One
|
July 4, 2008
A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients
Dao-Zhen Xu, Kai Zhao, Li-Min Guo, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
May 26, 2007
[The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52]
Ji-dong Jia, Jin-lin Hou, You-kuan Yin, et al.
World Journal of Gastroenterology
|
March 31, 2018
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection
Lai Wei, Fu-Sheng Wang, Ming-Xiang Zhang, et al.
Journal of Gastroenterology and Hepatology
|
October 13, 2018
Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL study
Lai Wei, Ji Dong Jia, Fu Sheng Wang, et al.
Journal of Digestive Diseases
|
July 24, 2020
Multicenter prospective study to validate a new transient elastography device for staging liver fibrosis in patients with chronic hepatitis B
Wei Jia Duan, Xiao Zhong Wang, An Lin Ma, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 194) with videos related to
Sort By:
Page
of 20
Nature Communications
|
April 5, 2019
NKG2A is a NK cell exhaustion checkpoint for HCV persistence
Chao Zhang, Xiao-Mei Wang, Shu-Ran Li, et al.
NAR Genomics and Bioinformatics
|
August 8, 2022
Mining bacterial NGS data vastly expands the complete genomes of temperate phages
Xianglilan Zhang, Ruohan Wang, Xiangcheng Xie, et al.
JAMA Network Open
|
February 24, 2025
Tetramethylpyrazine Nitrone in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial
Xiaolu Liu, Huifang Shang, Qianqian Wei, et al.
Journal of Digestive Diseases
|
February 2, 2018
Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo-controlled phase 2 trial
Yong Feng Wang, Jie Ting Tang, Tao Han, et al.
Hepatology International
|
July 24, 2015
Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients
Ji-Dong Jia, Jin-Lin Hou, You-Kuan Yin, et al.
Plos One
|
July 4, 2008
A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients
Dao-Zhen Xu, Kai Zhao, Li-Min Guo, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
May 26, 2007
[The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52]
Ji-dong Jia, Jin-lin Hou, You-kuan Yin, et al.
World Journal of Gastroenterology
|
March 31, 2018
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection
Lai Wei, Fu-Sheng Wang, Ming-Xiang Zhang, et al.
Journal of Gastroenterology and Hepatology
|
October 13, 2018
Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL study
Lai Wei, Ji Dong Jia, Fu Sheng Wang, et al.
Journal of Digestive Diseases
|
July 24, 2020
Multicenter prospective study to validate a new transient elastography device for staging liver fibrosis in patients with chronic hepatitis B
Wei Jia Duan, Xiao Zhong Wang, An Lin Ma, et al.
Page
of 20